• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 67 of 100
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health3 Highly Dubious Claims Mylan’s CEO Made to Congress
By Sy MukherjeeSeptember 26, 2016
Can a Pill Fix Your Hearing?
HealthCan a Pill Fix Your Hearing?
By Jennifer AlseverSeptember 26, 2016
How a Biotech Turned a Bust Into a Hit
HealthHow a Biotech Turned a Bust Into a Hit
By Jennifer AlseverSeptember 26, 2016
How Time Warner’s Former CEO Is Helping Democratize Cancer Research
LeadershipHow Time Warner’s Former CEO Is Helping Democratize Cancer Research
By Sy MukherjeeSeptember 23, 2016
Attorney general Loretta Lynch said the department will issue a new plan next week.
Health35 US States Are Suing This Opioid Maker for Anticompetitive Practices
By ReutersSeptember 23, 2016
Herpes Treatment
HealthThis Acne Treatment Now Costs Almost $10,000
By Madeline FarberSeptember 21, 2016
Senate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
HealthSenate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
By ReutersSeptember 21, 2016
The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
FinanceBayer Shares Rise After It Ups Sales Targets for Top-Selling Drugs
By ReutersSeptember 20, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
HealthNovartis Says MS Drug Cut Risk of Disability Advance in Study
By ReutersSeptember 17, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthA Minnesota Doctor Is Trying Get a $50 EpiPen Alternative to Market
By Sy MukherjeeSeptember 15, 2016
Meet the Federal Government’s Pot Dealer
HealthMeet the Federal Government’s Pot Dealer
By Andrew Joseph and STAT NewsSeptember 15, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
HealthMylan Reportedly Paid Its Executives More Than Bigger Rivals
By Tom Huddleston Jr.September 14, 2016
Mylan EpiPen; epinephrine injection, 0.3 mg
HealthThis Vote Could Finally Make a Difference in Crazy Drug Prices
By Sy MukherjeeSeptember 14, 2016
GERMANY-AGRICULTURE-BAYER-MONSANTO-MERGER
FinanceBayer, Monsanto Agree to Merge in $66 Billion Deal
By Reuters and Fortune EditorsSeptember 14, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan Agrees to Hand Over EpiPen Documents to Congress
By Sy MukherjeeSeptember 13, 2016
1...
  • 65
  • 66
  • 67
  • 68
  • 69
...100
Most Popular
Economy
‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debtplaceholder alt text
By Jacqueline MunisMay 10, 2026
Tech
OpenAI CEO Sam Altman says Gen Z and millennials are using ChatGPT like a 'life advisor'—but college students might be one step aheadplaceholder alt text
By Sydney LakeMay 10, 2026
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.